688739 成大生物
按盤價 
26.190 +0.120 (+0.460%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.739 | 3.578 | 4.841 | 7.515 | 13.251 |
| 總資產報酬率 ROA (%) | 1.660 | 3.406 | 4.628 | 7.195 | 12.508 |
| 投入資產回報率 ROIC (%) | 1.736 | 3.569 | 4.826 | 7.490 | 13.198 | 邊際利潤分析 |
| 銷售毛利率 (%) | 79.630 | 82.938 | 83.650 | 87.114 | 89.851 |
| 營業利潤率 (%) | 19.359 | 24.200 | 33.015 | 46.246 | 48.979 |
| 息稅前利潤/營業總收入 (%) | 16.656 | 20.845 | 28.800 | 42.972 | 49.201 |
| 淨利潤/營業總收入 (%) | 15.039 | 20.452 | 26.623 | 39.340 | 42.743 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 110.202 | 119.163 | 112.110 | 97.586 | 98.596 |
| 價值變動淨收益/利潤總額(%) | 8.968 | -4.434 | 5.747 | 3.252 | 1.378 |
| 營業外收支淨額/利潤總額(%) | -0.478 | -0.651 | -0.246 | -0.154 | 0.803 | 償債能力分析 |
| 流動比率 (X) | 20.686 | 18.010 | 20.317 | 28.228 | 26.980 |
| 速動比率 (X) | 19.280 | 16.840 | 19.133 | 26.471 | 25.647 |
| 資產負債率 (%) | 4.239 | 4.866 | 4.783 | 4.039 | 4.500 |
| 帶息債務/全部投入資本 (%) | -0.773 | -0.802 | -0.976 | -1.100 | -1.205 |
| 股東權益/帶息債務 (%) | -12,911.678 | -12,448.351 | -10,216.152 | -9,068.384 | -8,265.151 |
| 股東權益/負債合計 (%) | 2,258.848 | 1,955.038 | 1,990.571 | 2,375.782 | 2,122.005 |
| 利息保障倍數 (X) | -6.379 | -6.518 | -6.967 | -13.415 | -282.688 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 276.814 | 231.847 | 225.605 | 205.242 | 126.644 |
| 存貨周轉天數 (天) | 556.452 | 555.330 | 567.585 | 665.725 | 566.538 |
| 備註： | 即時報價更新時間為 08/01/2026 10:28 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
